3. Bladder Cancer Symposium

In diesem Jahr standen vor allem urinbasierte Tumormarker sowie Urin-Proteomics im Fokus des Blasenkrebs-Symposiums. Einzelne Vorträge können hier eingesehen werden:

Welcome and introduction,
Thomas Brüning, IPA

Urine proteomics - Workflow and technologies: pitfalls and challenges,
Antonia Vlahou, Bioacademy Athens

Development of urniary peptide markers - The perspective of biotechnology,
Harlad Mischak, Mosaiques diagnostics

Changes in protein expression associated with exposure to bladder carcinogens,
Simone Schmitz-Spanke, University of Duisburg-Essen

National prospective cohort studies: Urine sampling, biobanking and -omics technologies for the retrospective performance of markers,
Thomas Illig, Helmholtz Zentrum München

Petides, proteins and protein identification: challenges of analysing, storing and handling large dadasets,
Rolf Apweiler, European Bioinformatics Institute

Assessing potential confounders for urine-based markers,
Beate Pesch, Volker Harth, IPA

From proteomics to tumor markers,
Helmut E. Meyer, Kai Stühler, Ruhr University Bochum

Round table discussion

Zum ausführlichen Programm: mehr

Hier geht es zu den Vorträgen des 2. Bladder Cancer Symposiums aus dem Jahr 2009